Lastly, despite RTN4 reflecting major pathologies underlying MS (i.e., neurodegeneration and neuroinflammation), the combined analysis of NfL and RTN4 did not improve the accuracy of early diagnosis of MS patients. Here, RTN4 is linked to myeloid sarcoma.